Heublein, S., Marmé, F., & Kommoss, S. (2019). Fibroblast growth factor receptor 4 (FGFR4) as detected by immunohistochemistry is associated with postoperative residual disease in ovarian cancer. Journal of cancer research and clinical oncology, 145(9), . https://doi.org/10.1007/s00432-019-02986-0
Chicago-Zitierstil (17. Ausg.)Heublein, Sabine, Frederik Marmé, und Stefan Kommoss. "Fibroblast Growth Factor Receptor 4 (FGFR4) as Detected by Immunohistochemistry Is Associated with Postoperative Residual Disease in Ovarian Cancer." Journal of Cancer Research and Clinical Oncology 145, no. 9 (2019). https://doi.org/10.1007/s00432-019-02986-0.
MLA-Zitierstil (9. Ausg.)Heublein, Sabine, et al. "Fibroblast Growth Factor Receptor 4 (FGFR4) as Detected by Immunohistochemistry Is Associated with Postoperative Residual Disease in Ovarian Cancer." Journal of Cancer Research and Clinical Oncology, vol. 145, no. 9, 2019, https://doi.org/10.1007/s00432-019-02986-0.